Alumni Ventures is a venture capital firm based in Manchester, New Hampshire, with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo. It enables accredited investors, especially alumni networks, to access diversified venture opportunities by co-investing alongside leading venture capital firms. Through funds, syndicates, and investing clubs, it sources opportunities across stages and geographies, conducts rigorous due diligence, and aims for transparent, founder-friendly support. The firm backs a diversified portfolio of startups, including more than 1,600 companies, and has attracted substantial committed capital and a large community of individual investors, underscoring its mission to democratize access to venture capital while partnering with established VC firms.

General Catalyst is a venture capital firm that funds early-stage and growth companies across sectors including consumer, enterprise software, fintech, crypto, and healthcare. Based in San Francisco with offices in Cambridge, Massachusetts and other locations, it provides capital and strategic guidance to help entrepreneurs build scalable, durable businesses. The firm emphasizes the use of technology, including artificial intelligence, to accelerate growth and drive meaningful impact. General Catalyst partners with management teams to support product development, go-to-market strategies, and organizational growth, aiming to back companies with potential for wide adoption and long-term value creation, rather than focusing solely on near-term exits.

City Light Capital is a New York-based venture capital firm founded in 2004 that invests in early- and growth-stage U.S. companies pursuing technology-enabled solutions in education, climate and environment, safety and care, and healthcare. It prioritizes revenue-generating businesses that deliver measurable social impact, aiming to back category-defining companies and scale their positive outcomes. The firm emphasizes data-driven decision-making and hands-on support to help portfolio companies reach scale, with investments across stages while maintaining a focus on scalable impact.

Gaingels is a venture investment syndicate focused on supporting LGBTQ founders and inclusive leadership by investing across stages and partnering with other venture firms to back diverse, high-potential companies. It maintains a global portfolio of 130+ companies and has deployed tens of millions in capital to date. The organization actively helps portfolio companies identify and recruit diverse talent for C-suite and board roles and cultivates a worldwide network of investors, operators, and entrepreneurs who share a commitment to positive social change through business.

SOSV is a global venture capital firm that provides early-stage and seed investments alongside structured accelerator programs and deeply resourced facilities to accelerate product development. Focused on deep tech, human and planetary health, and cross-border software, SOSV backs startups from pre-seed onward and runs programs that accelerate technical development, regulatory strategy, and fundraising. The firm maintains labs and engineering spaces with specialist staff in multiple regions, including the United States and Asia, to support portfolio companies in biosafety, chemistry, mechatronics, analytics, and electrical engineering. Programs such as HAX and other live events offer founders access to prototyping, testing, and investor networks. Annually, SOSV makes around sixty pre-seed investments (up to roughly $550k each) and participates in numerous follow-on rounds, leveraging a global portfolio and extensive co-investor network to help deeply technical startups scale and reach markets.

Flare Capital Partners is a Boston-based venture capital firm focused on healthcare technology. It backs early-stage and growth-stage companies across the United States, investing in software, data, artificial intelligence, digital health, medical devices, and related healthcare IT solutions that enable value-based care. The firm emphasizes transformational technologies and leverages a network-driven engagement model, including an AI Advisory Council and Industry Advisory Board of healthcare leaders, to support portfolio companies and accelerate adoption with near-term ROI. Its approach aims to connect innovators with buyers and to generate impact within the broader healthcare economy.

Right Side Capital Management is a San Francisco-based venture capital firm founded in 2012 that targets early-stage, capital-efficient technology startups in the United States and Canada. The firm employs a data-driven, quantitative approach to investment decisions and aims for rapid yes-or-no conclusions, often within two weeks. Typical rounds encompass small checks in the low hundreds of thousands, with the potential for larger commitments in exceptional cases, and a portfolio-wide strategy that emphasizes diversification. Beyond capital, it provides hands-on mentorship in areas such as sales, marketing, and fundraising, leveraging a network of investors and seasoned operators to support portfolio companies after investment. The firm focuses on teams still refining product-market fit, including those outside traditional tech hubs, and seeks to help founders scale efficiently through structured operational support and transparent decision processes.

What If Ventures is a venture capital firm based in Frisco, Texas, focused on disruptive healthcare and defense startups. It makes investments in companies developing innovative solutions and has a portfolio that includes Alto Neuroscience, Atai Life Sciences, and Firehawk. The firm emphasizes opportunities at the intersection of health and defense markets, which feature large addressable markets, complex regulatory environments, and strong government and commercial customers. Since its inception around 2019–2020, What If Ventures has deployed substantial capital into multiple disruptive ventures. In addition to investing, the firm provides intelligence data services through Umbra and shares industry insights via blogs and engagement programs such as fellowships and funding opportunities.

Goodwater Capital is a California-based venture capital firm founded in 2014 that focuses on early-stage investments in consumer technology and related sectors. Based in Burlingame, it backs entrepreneurs developing products and platforms with broad consumer appeal across industries such as housing, financial services, healthcare, education, retail, transportation, and entertainment. The firm emphasizes backing ventures that can improve lives at scale through technology and drive positive global impact. Its portfolio spans consumer technology, ecommerce, fintech, and services with a global footprint, including notable investments in Zepto, Weee!, Toss, and Monzo.

Andreessen Horowitz is a Menlo Park, California-based venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz. It funds technology startups across seed to late stages, with investments spanning software, cloud infrastructure, enterprise software and services, consumer internet, fintech, artificial intelligence, crypto, infrastructure, and biotechnology at the intersection of computer science and life sciences. The firm emphasizes supporting portfolio companies through growth and strategic partnerships and maintains a broad tech-focused investment approach, aiming to add value beyond capital.

StartUp Health is a global health innovation organization founded in 2011 that supports entrepreneurs and health innovators to improve health and wellbeing. It partners with a broad ecosystem of founders, funders, and healthcare leaders to pursue health moonshots such as access to care, cure disease, end cancer, women’s and children’s health, mental health, and pandemic response. It operates the world’s largest portfolio of health technology companies, with more than 330 companies across six continents and 26 countries, and is backed by major health systems and investors including Kaiser Permanente, Masimo, Novartis, Otsuka, Ping An, Steve Case, Mark Cuban, and Esther Dyson. The organization focuses on collaboration, knowledge sharing, and ecosystem programs that connect startups, scaleups, established companies, and providers, and it hosts events to accelerate progress in priority health areas.

Blue Venture Fund is the corporate venture capital arm of the BlueCross BlueShield Association, established to fund innovation in healthcare by investing in technology, services, and clinical sciences companies across stages from seed to buyout. It seeks to improve health outcomes, enhance patient experience, and reduce costs, aligning portfolio companies with the needs of BCBS member plans. By leveraging the network and expertise of Blue Plan partners, the fund connects portfolio companies with potential customers and pathways to commercialization, focusing on delivering value to Blue Plan members. Based in Chicago, the fund operates within the broader BCBS ecosystem to support healthcare innovation.

Mystic Ventures is an early-stage venture capital firm based in Los Angeles that backs startups developing psychedelic medicines, neuropsychiatric and CNS therapies, and related biotechnology solutions. The firm evaluates opportunities at the intersection of psychedelic medicine, consciousness expansion, biotechnology, AI, and longevity, and focuses on pre-seed and seed-stage companies with potential to advance mental health and mind-body optimization. Leveraging a broad network across medical professionals, academics, and industry experts, Mystic Ventures supports founders with deal flow, validation, and strategic resources to bring high-quality therapies and digital therapeutics to market amid a growing scientific and societal interest in psychedelic-assisted treatments.

8VC is a San Francisco-based technology and life sciences investment firm that partners with founders to develop transformational technologies and create long-term economic and societal value. It invests across sectors including healthcare and life sciences, energy, IT infrastructure, enterprise software, logistics, government and defense, manufacturing, consumer products, and financial services, with a focus on opportunities that leverage data-driven decision making. The firm supports portfolio companies through programs such as the 8VC Fellowship and 8VC Build and aims to back ventures where existing solutions do not meet market needs. 8VC manages a family of venture funds, including Entrepreneurs Fund II and III and multiple Fund I–III vehicles, reflecting a broad platform designed to accelerate growth and industry transformation.

GreyMatter is a San Francisco-based venture capital firm focused on investing in mental health and emotional wellbeing companies. Founded in 2021, it supports bold founders developing innovative approaches to mental health with strategic guidance and capital, aiming to accelerate progress and reshape the future of mental healthcare.

Rethink Impact is a venture capital firm that focuses on backing technology-driven companies addressing global challenges in health, education, environmental sustainability, and economic empowerment. Headquartered in White Plains, New York, with additional offices in San Francisco and Washington, DC, the firm targets mission-driven founders, particularly those led by women or with prominent female leaders, and invests in minority and women-owned companies. It provides growth capital in the range of roughly two to fifteen million dollars, supporting late Seed through Series C rounds and beyond as needed to accelerate scale. The firm emphasizes ESG and impact investing, aiming to generate positive social and environmental outcomes while delivering financial returns, and supports portfolio companies with strategic guidance to leverage mission as a competitive advantage.

Khosla Ventures is a California-based venture capital firm founded in 2004 that provides capital and strategic support to technology-driven startups across early- to late-stage cycles. It pursues opportunities in AI, digital health, healthcare technologies, sustainability, fintech, consumer and enterprise technology, and other frontier areas, focusing on innovative business models and world-class teams. The firm emphasizes a contrarian, long-term approach and seeks to help entrepreneurs address meaningful societal and economic challenges through science, technology, and design.

Based in Boston, Massachusetts, .406 Ventures is an early-stage venture capital firm that backs B2B technology companies in the Northeast United States. It focuses on information technology and services, cybersecurity, cloud and data infrastructure, next-generation software, AI, fintech, digital health, and technology-enabled business services. The firm typically acts as lead or first institutional investor in de novo and early-stage rounds, reserves capital for follow-ons, and provides strategic guidance through domain expertise and networks to help founders scale. Initial investments usually range in the low to mid single millions, with total commitments up to about $10 million per company. The approach emphasizes long-term partnerships with entrepreneurs to build market-leading companies.

Everywhere Ventures is a New York based venture capital firm focused on pre-seed and early-stage startups worldwide. Founded in 2017, it operates as a community-powered platform that pools capital, mentorship, and strategic introductions through ten micro funds, backed largely by more than 500 founder and operator limited partners. The firm invests in early rounds across sectors including software, money, health, and work, providing hands-on support and practical guidance to founders from inception to traction. It emphasizes founder-led collaboration and peer learning, leveraging the experience of operators and entrepreneurs who have built successful companies to help the next generation of startups.

PsyMed Ventures is a San Francisco-based venture capital firm founded in 2020 that backs early-stage companies advancing brain and mental health innovation. The firm focuses on neuroscience-driven ventures across psychedelics medicine, neurotechnology, precision psychiatry, digital therapeutics, and related frontier technologies, supporting founders developing new compounds, diagnostics, and therapies for neurological and psychiatric disorders. With an emphasis on AI-enabled tools, innovative diagnostics, RNAi and CRISPR modalities, and holistic approaches, PsyMed Ventures seeks to foster collaboration and accelerate breakthroughs in mental health and brain health.

Ulu Ventures is a California-based venture capital firm founded in 2008 and headquartered in Palo Alto. It specializes in seed and early-stage technology investments across enterprise software, B2B and B2C platforms, healthtech, fintech, sustainability, edtech, blockchain, digital media, mobile, and internet-enabled services, with a preference for Bay Area opportunities. The firm often co-invests with other angels or venture firms, typically committing between $500,000 and $1 million. Ulu emphasizes diverse founder teams, including women and minority founders, and applies data-driven, risk-adjusted decision making to identify high-potential opportunities. It operates as a registered investment adviser and focuses on markets where there is potential for scalable exits. The overview highlights Ulu’s trajectory as a seed and early-stage investor backing disruptive ideas within the technology sector.

FJ Labs is a New York-based venture capital firm that focuses on marketplaces and consumer-facing startups. It is stage-agnostic, backing seed and Series A rounds, with an investment range of fifty thousand to five million dollars. Founded in 2015 by Fabrice Grinda, the firm leverages its network and experience in the marketplace sector to support founders aiming for rapid growth. The firm maintains a broad portfolio across e-commerce, on-demand services, fintech, and related technologies, with notable investments in Alibaba, Coupang, Delivery Hero, Beepi, BrightRoll, Betterment, Adore Me, and Earnest. FJ Labs emphasizes partnerships with visionary founders and uses its sector expertise to help portfolio companies scale and achieve expansion.

Operator Partners is a New York-based investment firm founded in 2020 that backs technology companies from early stage through Series B. It focuses on the technology sector and supports founders as they grow. The firm emphasizes operational involvement, offering hands-on guidance to portfolio companies on business building and scaling between board meetings, with the goal of timely investment decisions. Operator Partners operates with its own capital rather than external investors, presenting a partner-oriented approach that leverages practical company experience to respect founders’ time and accelerate growth.

Town Hall Ventures is a New York-based venture capital firm established in 2018 that concentrates on early-stage healthcare companies across the United States, with a particular emphasis on technology-enabled care delivery and health outcomes for underserved and high-need populations. The firm targets Series A and Series B investments in healthcare technology and related services, aiming to transform the U.S. health care market. It differentiates itself through substantial, hands-on support and by leveraging strategic relationships to help founders build meaningful, scalable businesses. Town Hall partners with entrepreneurs to accelerate growth and improve access to care in areas such as mental health, senior care, rural health, and other underserved segments, seeking category-defining opportunities that can impact millions of lives.

Lionheart Ventures is a global seed-stage venture capital firm focused on transformative technologies, with an emphasis on artificial intelligence and frontier mental health. The firm seeks to mitigate civilizational risk by backing exceptional, ethical founders developing innovations that can meaningfully improve human flourishing while delivering attractive returns for investors. It emphasizes principled investing and responsible technology stewardship, supported by a team of former founders and a network of expert advisers. Lionheart pursues opportunities in multi-billion-dollar markets and has backed companies such as Calm, Lucid Computing, and Reconnect Labs, representing interests in wellness, data sovereignty, and regenerative therapeutics for mental health.

BoxGroup, founded in 2009, is a New York-based venture capital firm that backs early-stage technology startups, typically at pre-seed to Series A, across sectors including consumer, enterprise software, fintech, healthcare, life sciences, SaaS, marketplaces, e-commerce, climate tech, and frontier technologies. The firm emphasizes supporting solo founders and bold ideas, evaluating teams with conviction and aiming to fund ventures at the start of emerging markets. Investment sizes vary from tens of thousands to around a million dollars, with a global outlook and a stated focus on New York City, Silicon Valley, and Los Angeles, though geography is not a constraint. BoxGroup operates as a boutique investor in the early stages of portfolio companies, often engaging without taking board seats.

Calm/Storm Ventures is a boutique venture capital firm based in Vienna, Austria, founded in 2019, focused on HealthTech and digital health. It provides growth capital and early-stage funding, including pre-seed and Series A, and makes investments across Europe and the United States. The firm backs purpose-driven founders and seeks to generate both impact and financial returns, building a diverse HealthTech portfolio. It is noted for an active HealthTech footprint in Europe since 2020, and for publishing industry insights such as the Digital Health Compass and related founder-focused content.

Deerfield Management is a New York City-based healthcare investment and information platform that advances healthcare through flexible funding models, AI-driven intelligence, and philanthropy. It connects people, capital, ideas, and technology across the healthcare ecosystem by investing in and building companies, powered by Deerfield Discovery and Development (3DC), a company-building R&D engine where bench scientists and industry veterans collaborate, and Cure, a New York City hub housing portfolio companies and in-building labs with advanced equipment. It has partnered with Blue Cross Blue Shield of North Carolina to build Alo, a platform enabling independent physicians to manage the business of medicine. Its Intelligence offering leverages AI, data, and market research to drive healthcare technology and innovation, while the Deerfield Foundation funds philanthropic initiatives in education, healthcare access, and health outcomes. The firm pursues strategic partnerships and external collaborations to accelerate progress across biotechnology, pharmaceuticals, diagnostics, devices, and services.

Difference Partners is a New York-based venture capital firm founded in 2021 that invests in technology companies designed to improve the lives of people who learn and think differently, including individuals with autism, ADHD, dyslexia and other neurodiversity considerations. It focuses on education, healthcare, accessibility and workplace enablement, addressing needs in learning disabilities, mental health and related areas. The firm supports growth through strategic investments and collaborations, backed by a dedicated team.

Refactor is a seed-stage venture firm led by Zal Bilimoria and based in Burlingame, California. It backs US-based hard-tech startups that build physical systems—atoms, not bits—with a founder-first approach and early checks. The firm targets durable moats, long development cycles, and sticky customer value across aerospace, energy, bio, critical materials, immune health, and AI infrastructure. Its portfolio includes Clover Health, Uniform Teeth, Kip, and other ventures that have achieved notable outcomes, including Clover Health’s public listing and Uniform Teeth’s acquisition by Impress and Kip’s acquisition by Modern Health. Refactor originated as an early spinout connected to a16z’s Bio Fund and remains focused on supporting ambitious teams rebuilding industries. Based in Burlingame, the firm invites founders to pitch and emphasizes measurable, durable impact over rapid exits.

ULTRA.VC is a venture capital firm with an in-house accelerator based in Limassol, Cyprus, backing European founders with global ambitions at the early stage. It provides seed funding from 50,000 to 300,000 with follow-on options, plus mentorship, progress tracking, workshops, and access to a curated network of angels and VCs. The firm concentrates on ventures where technology enhances human potential and quality of life in areas such as personal and mental wellbeing, education, lifelong learning, the future of work, governance, fintech with impact, and ethical AI. It pursues a focused, small-batch approach to support a limited number of teams per cohort, aiming to accelerate growth and foster a strong founder community. ULTRA.VC seeks innovative solutions, values a capable team and a global mindset, and encourages applications from startups addressing meaningful problems even if they span multiple verticals.

Palo Santo is an early-stage venture capital firm based in Chicago that invests in breakthrough mental health and neurological therapeutics. Its focus includes differentiated CNS targets, next-generation psychedelic medicines, and cutting-edge research tools that advance translational neuroscience and clinical translation.

Forum Ventures is a founder-first venture studio, accelerator, and early-stage seed fund that supports B2B software startups. Founded in 2014 as Acceleprise, it focuses on helping founders from concept to market and funding through hands-on studio involvement, a 15-week pre-seed program with structured mentorship and funding, and a seed fund that backs startups at the seed stage. The organization operates a community and network to facilitate go-to-market strategies, fundraising, and partnerships, drawing on a portfolio of over 250 companies and connections with leading venture firms. It emphasizes founder welfare and practical support across product development, customer discovery, and fundraising, aiming to simplify the B2B SaaS journey for early-stage founders.

Wisdom Ventures is a San Francisco Bay Area venture capital firm that concentrates on seed-stage investments in tech-enabled wellbeing and human-connectivity solutions, backing startups across sectors such as artificial intelligence, mental and physical health, mindfulness, compassion, and employee well-being, with a global investment reach and a network of experienced partners and leaders, and focusing on supporting builders creating more connected, humane, and resilient communities through technology that is ethically minded and socially impactful.

Bossa Invest is a venture capital firm based in São Paulo, Brazil, founded in 2011. It focuses on software-as-a-service startups in Latin America, providing growth capital, mentorship, and access to a broad network of strategic partners and co-investors to help portfolio companies scale, and operates a corporate venture capital arm that collaborates with corporate partners through flexible operating models and end-to-end support.

HealthTech Capital is an angel investor group focused on health technology and medical technology startups. Founded in 2010 and based in Los Altos Hills, California, it accelerates healthcare innovation by connecting healthtech startups with accredited angel investors, healthcare systems, venture capitalists, and corporate investors. The organization provides investment and customized mentoring programs, facilitating early-stage funding and ongoing collaboration across clinical providers, venture and corporate partners. It aims to create an ecosystem that includes leading clinical providers, venture firms, and strategic industry players, and has supported portfolio companies with over one billion dollars in follow-on capital. Its membership spans entrepreneurs, clinicians, executives, venture capitalists, and corporate investors nationwide, emphasizing market collaboration and opportunities for early-stage innovation.

Noetic Fund is a Toronto-based venture capital firm that invests globally in early-stage companies spanning mental health, CNS-focused therapeutics, digital health, medical devices, and wellness. It supports molecular therapeutics and biotech, psychedelic-assisted therapies, and other evidence-based modalities aimed at advancing scientific understanding and improving human health. The firm pursues a multi-modal portfolio strategy, backing ventures that address mental and emotional well-being as well as physiological conditions, with emphasis on CNS-targeted therapies and sustainable health solutions. Its portfolio includes digital health tools, wearables, and related technologies, reflecting a commitment to governance, scientific rigor, and impactful execution. Noetic Fund seeks to nurture scientific advancement by supporting emerging therapies and modalities worldwide, with the objective of making effective mental health and wellness solutions accessible to current and future generations.

Able Partners is a New York-based venture capital firm focused on early-stage investments in health and wellness, the care economy, consumer wellbeing, and related disruption. The firm partners with founders to support growth, pursuing flexible paths to scale and exit, and aims to help brands reach broader audiences and improve daily life. Led by Amanda Eilian, Able Partners backs entrepreneurs across telehealth, biotech, sustainable brands, and personalized health solutions, reflecting a commitment to closing the wellness gap and strengthening health ecosystems.

Felicis Ventures is a Menlo Park, California-based venture capital firm founded in 2006 by Aydin Senkut that concentrates on early-stage investments in software, information technology and frontier technologies. The firm backs bold founders seeking to build market-defining companies and often leads or co-leads investments, while providing mentoring and advisory support beyond capital. Its portfolio spans AI, cybersecurity, health, energy and consumer internet, including unicorns such as Shopify, Canva and Notion, and represents 23 nationalities with investments in six countries outside the United States. Felicis emphasizes speed in deal-making, frequently completing term sheets within 24 hours.

Sequoia Capital is a California-based venture capital firm founded in 1972. It provides capital and strategic guidance to technology-focused startups, typically engaging with a limited number of portfolio companies at a time and supporting them through the business lifecycle. The firm emphasizes long-term partnerships, assisting with product development, company building, and market expansion as companies scale from idea to growth across global markets.

SignalFire is a San Francisco-based venture capital firm that backs seed- and early-stage technology companies. The firm emphasizes a data-driven approach, leveraging its Beacon AI Platform to track talent and market insights and to provide portfolio support in hiring, go-to-market, and fundraising. SignalFire differentiates itself with a technology-first model and a distributed network that connects portfolio companies with leading entrepreneurs, product and engineering talent across key disciplines and industries. The firm invests across sectors including healthtech, cybersecurity, fintech, consumer, and enterprise software, and supports portfolio companies with in-house AI/ML tools, talent search, and mentorship to accelerate growth. Founded in 2013, SignalFire positions itself as a modern VC that aims to supplement capital with deep operator-centric resources, helping founders navigate talent, strategy, and partnerships.

JAZZ Venture Partners is a San Francisco–based venture capital firm investing in startups at the intersection of technology, science, and humanity to improve how people live, work, and experience the world. The firm backs companies spanning healthcare, consumer technology, enterprise software, robotics, artificial intelligence, and frontier technologies, with a focus on digital technology, neuroscience, immersive media, and closed‑loop human–computer systems that enhance human performance. Led by operators, technologists, scientists, and entrepreneurs, JAZZ emphasizes human‑centered design, rigorous strategic analysis, and active portfolio support to help companies grow from seed to scale while delivering positive societal impact. The firm seeks ventures that combine science and technology to create durable platforms that advance everyday life.

Deep Track Capital is a biotechnology investment firm based in Greenwich, Connecticut. It focuses on the life sciences and biotech sector, forging partnerships with management teams of innovative public and pre-IPO biotechnology companies, and aims to invest time, expertise, and its network alongside capital to support partners. The firm seeks to lead transactions while forming large syndicates and to participate in rounds led by other qualified investors.

Menlo Ventures is a San Francisco-based venture capital firm, founded in 1976, that funds technology companies from seed to growth across consumer, enterprise, and life sciences. The firm emphasizes market-driven analysis and active involvement to identify opportunities in areas such as marketplaces, consumer services, software-as-a-service, fintech, cybersecurity, infrastructure, and digital health. Its diverse portfolio spans early-stage startups and later rounds, with notable investments in artificial intelligence, cloud, and life sciences technologies, and it has supported numerous companies through public offerings and acquisitions.

WPSS.bio is a New York–based venture capital firm that invests in startups focused on brain health and central nervous system care, including diagnostics and treatments, with an emphasis on preventative medicine and women's mental health. The firm backs ventures addressing significant unmet medical needs in these areas, supporting innovative teams developing transformative solutions that aim to improve patient outcomes.

Village Global is a San Francisco-based early-stage venture capital firm and accelerator founded in 2017. It funds technology startups at pre-seed and seed stages across sectors such as fintech, healthcare technology, software, artificial intelligence, information technology and mobile, typically investing in the lower to mid seven figures. Beyond capital, it provides a broad network of over 400 founders, operator angels and luminary LPs, offering founder retreats, peer dinners, masterclasses and access to an investor database. The firm emphasizes hands-on support for portfolio companies, including help with co-founder formation, fundraising, strategic introductions and mentorship, to help startups grow and navigate early-stage challenges through its ecosystem.

Founder Collective is a seed- and pre-seed-focused venture capital firm headquartered in Cambridge, Massachusetts, with offices in New York City and Boston. It backs early-stage technology startups across the United States with a founder-aligned, long-term approach that emphasizes capital efficiency and durable value over rapid ownership targets. The firm is sector-agnostic and prioritizes people and execution, partnering with exceptional founders from idea to IPO. Its portfolio includes notable companies such as Uber, SeatGeek, WHOOP, Shield AI, The Trade Desk, and Suno. The team combines hands-on partnership with an extensive network to support portfolio companies throughout growth and scale.

Tanglin Venture Partners is a Singapore-based venture capital firm founded in 2018 that invests in technology startups and fast-growing businesses. It partners with entrepreneurs, often pursuing early- to growth-stage opportunities, with cheque sizes up to several million and manages about $250 million across two active funds. The firm emphasizes focused, long-term relationships, thorough due diligence, and authentic founder engagement, guided by a thematic investment approach. Its portfolio includes Pocket FM, Lifelong, Moglix, Footprints Childcare, Plum Health Insurance, Matiks, and Scapia, among others, and the team maintains a hands-on approach to supporting portfolio companies' growth and innovation. The team is based in Singapore and Bengaluru, reflecting an Asia-centric footprint.

Virtue is a venture capital firm focused on early-stage healthcare investments, supporting founders in the pre-seed and seed phases and providing capital to promising healthcare ventures, with typical initial investments ranging from $500,000 to $4,000,000.

Liquid 2 Ventures is a San Francisco-based venture capital firm founded in 2015 by Joe Montana, Mike Miller, and Michael Ma. It provides seed- and early-stage capital to technology startups, occasionally supporting later rounds such as Series B, and often invests alongside co-investors. The firm emphasizes strategic introductions and hands-on guidance to help portfolio companies scale, with a focus on software, TMT, and other technology sectors. By partnering with founders and other investors, Liquid 2 Ventures aims to align capital with long-term company growth.